Molecular Science

About ProbGen Biotech

Founded with a vision to deliver world-class molecular screening pipelines, ProbGen Biotech combines state-of-the-art biochemistry, automation, and clinical insights to empower laboratories worldwide.

Pioneering Global Genomics Solutions

ProbGen Biotech India Private Limited was established to bridge the gap between high-level diagnostics research and accessible laboratory tools. Operating in the healthcare, medicinal chemicals, and botanical sciences sector, we deliver comprehensive In Vitro Diagnostic (IVD) systems from sample stabilization to bioinformatic insights.

DECEMBER 2023
Company Incorporation

ProbGen Biotech is incorporated, setting up registered laboratory arrays and R&D pipelines in Mohali, Punjab.

MID 2024
Assay Optimization

Validation and verification of GENPLEX™ qPCR Real-Time diagnostic profiles under state-certified laboratory benchmarks.

EARLY 2025
Global Expansion & Accreditation

Securing key industrial quality certifications, supplying diagnostics systems across global clinical grids.

Our Core Principles

Our work is driven by three foundational tenets, guiding every chemical formulation and bioinformatics algorithm we deploy.

Clinical Precision

We believe clinical diagnostics is a matter of absolute fidelity. Our qPCR primers and sequencing probes are manufactured under sterile clean-room environments to prevent amplification inhibitors.

Empowering Innovation

By leveraging Next-Generation Sequencing (NGS) multiplex targets and real-time fluorescent analysis, we provide diagnostic intelligence that simplifies complex genetic profiles.

Global Accessibility

Advanced healthcare shouldn't be a luxury. We design our molecular assays to be robust, stable, and cost-effective, assuring seamless integration in local and regional laboratories.

One Step Ahead

Founder's Desk

Sanjeev Kr. Chauhan

Founder, Chairman & CEO | Probgen Biotech India Pvt. Ltd.

Biotechnology Entrepreneur Molecular Diagnostics Clinical Genomics Cancer Diagnostics Next-Generation Sequencing
Sanjeev Kr. Chauhan is the Founder, Chairman and CEO of Probgen Biotech India Pvt. Ltd., a clinical diagnostics company focused on the development and manufacture of innovative diagnostic solutions. His professional profile combines biotechnology training, business management and an entrepreneurial focus on clinical diagnostics, clinical genomics, cancer diagnostics, next-generation sequencing (NGS), genetic research and advanced molecular technologies.

Leadership proposition: At Probgen Biotech, he leads the company's strategic direction and operations, with an emphasis on translating biotechnology into practical diagnostic products for laboratories and healthcare settings. The source profile positions innovation, quality and advanced diagnostics as central themes of the company's work.

Leadership & Strategic Focus

  • Corporate leadership: Founder-led direction of strategy, operations and growth.
  • Molecular diagnostics: Focus on PCR/RT-PCR and other molecular approaches for detection of infectious diseases, genetic mutations and pathogens.
  • Clinical genomics & NGS: Interest in clinical genomics and next-generation sequencing as advanced diagnostic platforms.
  • Cancer diagnostics: Focus on cancer-related diagnostic applications and biomarker-driven testing.
  • Innovation & R&D: Product innovation, research and development, and collaboration.
  • Healthcare impact: A long-term vision centred on expanding access to advanced diagnostic tools and contributing to healthcare.

Education

  • Biotechnology graduate — Punjab University, Chandigarh
  • Master's-level studies in Business Administration and Biotechnology Management — Amity University, Noida, Uttar Pradesh

Technology & Application Landscape

  • In-vitro diagnostic (IVD) products and genetic testing
  • PCR and RT-PCR based molecular diagnostics
  • Next-generation sequencing and clinical genomics
  • Cancer diagnostics and biomarker-related applications
  • Serology, immunoassay and point-of-care diagnostic concepts
  • Research, laboratory and public-health applications

Core Expertise

Leadership Corporate strategy • Entrepreneurship • Business management
Diagnostics Clinical diagnostics • IVD • Molecular diagnostics
Genomics Clinical genomics • Genetic testing • NGS
Disease Areas Infectious diseases • Cancer diagnostics • Genetic disorders
Technology PCR • RT-PCR • NGS • Immunoassay concepts
R&D Diagnostic product development • Innovation • Research orientation
Sanjeev Kr. Chauhan

Founder, Chairman & CEO | Probgen Biotech India Pvt. Ltd.

"One Step Ahead"

Advanced Diagnostic Infrastructure

ProbGen Biotech operates out of certified manufacturing centers utilizing state-of-the-art cleanrooms, automated liquid handlers, and high-performance genetic sequencer models.

Sterile cleanroom Facilities

Assay mixing and packing are completed under Class 100/ISO 5 sterile biosafety cabinets, preventing exogenous target DNA cross-contamination.

Rigid Validation Chemistry

Every single batch of enzymes, PCR buffers, and positive controls undergo exhaustive amplification curves testing prior to deployment.

Optimal Cold-Chain Integrity

Assay panels are stabilized for dynamic temperature variations, ensuring enzymes stay fully active during logistics transit.

R&D Lab Location

P. No. 03, Sector 08, Laxmi Ind Park, Sai, Derabassi, Mohali, Punjab - 140507, India